BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25162152)

  • 1. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
    Natsuizaka M; Chiba H; Kuronuma K; Otsuka M; Kudo K; Mori M; Bando M; Sugiyama Y; Takahashi H
    Am J Respir Crit Care Med; 2014 Oct; 190(7):773-9. PubMed ID: 25162152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
    Kondoh Y; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Homma S
    Respir Res; 2022 Feb; 23(1):24. PubMed ID: 35135550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.
    Saito S; Lasky JA; Hagiwara K; Kondoh Y
    Respir Investig; 2018 Sep; 56(5):375-383. PubMed ID: 30061050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
    Homma S; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Kondoh Y
    Respir Investig; 2022 Nov; 60(6):798-805. PubMed ID: 36068159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global incidence and prevalence of idiopathic pulmonary fibrosis.
    Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
    Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis.
    Yang SN; Perng DW; Ko HK; Chang YL; Hsu CC; Huang HY; Chung MI
    Healthcare (Basel); 2020 Dec; 8(4):. PubMed ID: 33371337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
    Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
    Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis in Taiwan - a population-based study.
    Lai CC; Wang CY; Lu HM; Chen L; Teng NC; Yan YH; Wang JY; Chang YT; Chao TT; Lin HI; Chen CR; Yu CJ; Wang JD
    Respir Med; 2012 Nov; 106(11):1566-74. PubMed ID: 22954482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
    Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
    Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
    Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.
    Oda K; Yatera K; Fujino Y; Ishimoto H; Nakao H; Hanaka T; Ogoshi T; Kido T; Fushimi K; Matsuda S; Mukae H
    BMC Pulm Med; 2016 Jun; 16(1):91. PubMed ID: 27278093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Yoo H; Jeong BH; Chung MJ; Lee KS; Kwon OJ; Chung MP
    BMC Pulm Med; 2019 Aug; 19(1):149. PubMed ID: 31412851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF.
    Nagai S; Kitaichi M; Hamada K; Nagao T; Hoshino Y; Miki H; Izumi T
    Sarcoidosis Vasc Diffuse Lung Dis; 1999 Sep; 16(2):209-14. PubMed ID: 10560125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.